ISSN: 1359-6535

Journal Home

Journal Guideline

Antiviral Therapy Q3 Unclaimed

Sage Publications United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Antiviral Therapy is a journal indexed in SJR in Infectious Diseases and Pharmacology with an H index of 93. It has an SJR impact factor of 0,447 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,447.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Infectious Diseases (Q3) Pharmacology (Q3) Pharmacology (medical) (Q3) Pharmacology (medical) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,447

SJR Impact factor

93

H Index

24

Total Docs (Last Year)

105

Total Docs (3 years)

935

Total Refs

154

Total Cites (3 years)

102

Citable Docs (3 years)

1.45

Cites/Doc (2 years)

38.96

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Influenza Research and Treatment Q3
Intervirology Q3
Microbial Risk Analysis Q3
AIDS Research and Human Retroviruses Q3
Southern African Journal of HIV Medicine Q3

Compare this journals

Aims and Scope

Best articles by citations

Effect of newer oral antiviral agents on future therapy of chronic hepatitis B

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women

Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014)

Association of genetic variation in IL28B with hepatitis C treatment-induced viral clearance in the Chinese Han population

Therapeutic drug monitoring guided raltegravir dosing for prevention of vertical transmission in a premature neonate born to a woman living with perinatally acquired HIV

Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic

Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop

Pharmacokinetic parameters of once-daily rilpivirine following administration of efavirenz in healthy subjects

How often does treatment of primary HIV lead to post-treatment control?

Long-term adherence to antiretroviral therapy in resource-limited settings: a bitter pill to swallow

Intracellular expression of an anti-idiotypic antibody single-chain variable fragment reduces porcine reproductive and respiratory syndrome virus infection in MARC-145 cells

HSV susceptibility to acyclovir -genotypic and phenotypic characterization

SHOW MORE ARTICLES

Protective murine and human monoclonal antibodies against eczema vaccinatum

Incident hyperglycaemia among older adults with or at-risk for HIV infection

Review of drug interactions with telaprevir and antiretrovirals

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

The value of screening HIV-infected individuals for didanosine-related liver disease?

High incidence of lamivudine-resistance associated vaccine-escape HBV mutant among HIV-coinfected patients on prolonged antiretroviral therapy

Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up

Pre-treatment antiviral resistance in Australians with chronic hepatitis C: prevalence of NS3 and NS5A resistance data in the state of New South Wales

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial

Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design

Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis

The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women